# KCNJ5 ## Overview The KCNJ5 gene encodes the potassium inwardly rectifying channel subfamily J member 5 (Kir3.4), a critical component of the G-protein-activated inwardly rectifying potassium (GIRK) channels. These channels are integral membrane proteins that play a vital role in maintaining the resting membrane potential and regulating cellular excitability by facilitating the inward flow of potassium ions. Kir3.4 is predominantly expressed in the adrenal gland and heart, where it contributes to aldosterone production and cardiac electrophysiology, respectively. The protein forms part of a tetrameric channel complex, which can be composed of either homotetramers or heterotetramers with other GIRK subunits. Mutations in KCNJ5 have been linked to various clinical conditions, including aldosterone-producing adenomas and cardiac arrhythmias, underscoring its significance in both endocrine and cardiovascular health (Meyer2023Relevance; Hibino2010Inwardly; Mulatero2012Role). ## Structure The KCNJ5 gene encodes the Kir3.4 protein, a subunit of the G-protein-activated inwardly rectifying potassium (GIRK) channels. The Kir3.4 protein is part of a tetrameric complex that can form either homotetramers or heterotetramers with other subunits like Kir3.1 (KCNJ3) (Meyer2023Relevance; Mulatero2012Role). Each subunit of the channel contains two transmembrane alpha-helices and a pore-forming loop, which is crucial for ion selectivity (Meyer2023Relevance). The pore domain includes a conserved Gly-Tyr-Gly sequence, typical of K+ selective channels (Mulatero2012Role). The protein's structure is further characterized by intracellular N-terminal and C-terminal regions. The C-terminal region is essential for the channel's localization to the cell surface, while specific amino acids in this region are necessary for the formation of functional heterotetramers (Meyer2023Relevance). Structural modeling has shown that mutations in the selectivity filter, such as I157S, can disrupt the channel's ion selectivity by causing conformational changes (Charmandari2012A). These structural features are critical for the channel's role in maintaining membrane potential and ion homeostasis in various tissues, including the heart and adrenal gland (Meyer2023Relevance). ## Function The KCNJ5 gene encodes a protein that is part of the G protein-sensitive inwardly rectifying potassium channels, specifically known as Kir3.4 or GIRK4. These channels are crucial for maintaining the resting membrane potential and regulating cellular excitability by allowing potassium ions to flow more easily into the cell than out. In healthy human cells, KCNJ5 is primarily expressed in the adrenal gland, particularly in the zona glomerulosa of the adrenal cortex, where it plays a significant role in aldosterone production. This process is mediated through the activation of voltage-gated Ca2+ channels following increased sodium conductance and cell depolarization due to KCNJ5 activity (Nishikido2020Regulation). In the heart, KCNJ5 forms part of the G-protein-activated inwardly rectifying potassium channel complex, which is involved in cardiac electrophysiology. These channels contribute to heart rate variability by mediating parasympathetic effects through the muscarinergic M2-receptor, influencing cardiac rhythm and action potential duration (Hibino2010Inwardly; Binas2019miR221). The protein's activity is regulated by interactions with G protein subunits, which facilitate rapid channel activation in response to physiological stimuli (Hibino2010Inwardly). ## Clinical Significance Mutations in the KCNJ5 gene are significantly associated with aldosterone-producing adenomas (APAs) and primary aldosteronism, a condition characterized by excessive aldosterone production leading to hypertension. These mutations, such as G151R, L168R, and T158A, alter the selectivity filter of the potassium channel, increasing sodium conductance and causing cellular depolarization. This results in the activation of voltage-gated calcium channels, promoting aldosterone secretion and cell proliferation, which contribute to the development of APAs (Scholl2013New; Tauber2014Pharmacology; Hattangady2016Mutated). KCNJ5 mutations are more prevalent in women and are linked to higher plasma aldosterone levels, although they do not affect adenoma size or surgical outcomes (Scholl2013New). In familial hyperaldosteronism type III (FH-III), specific KCNJ5 mutations, such as T158A, lead to severe hypertension and hypokalemia, often requiring surgical intervention (Mulatero2012Role). Beyond endocrine disorders, KCNJ5 variants have been implicated in cardiac pathologies, including atrial fibrillation and sinus node dysfunction. These conditions arise from disrupted channel activation and altered sinoatrial node pacemaker activity, highlighting the gene's role in both endocrine and cardiac health (Meyer2023Relevance). ## Interactions KCNJ5, encoding the GIRK4 protein, is involved in various protein interactions that are crucial for its function in cellular excitability and signal transduction. GIRK4 forms part of the G-protein-activated inwardly rectifying potassium (GIRK) channels, which are essential for modulating cardiac electrical activity. These channels interact with G-protein subunits, particularly Gβγ, to facilitate channel activation. Mutations in KCNJ5, such as R52H and E246K, impair the interaction with Gβγ, leading to non-functional channels (Shalomov2022A). KCNJ5 also participates in multiprotein complexes, influencing cardiac electrophysiology. The protein interacts with other ion channels and regulatory proteins, which are significant for maintaining proper channel expression and function. In cardiac tissue, KCNJ5 has been identified to have 45 protein interactors, highlighting its role in complex protein networks that regulate cardiac function (Maurya2023Outlining). Additionally, KCNJ5 is a target of miR-208b, a microRNA that binds to its 3'-UTR, affecting its expression. This interaction has functional implications for ion current regulation in cardiomyocytes, as demonstrated by reduced carbachol-induced thallium current in cells transfected with miR-208b mimics (Hupfeld2021miR208b). ## References [1. (Charmandari2012A) Evangelia Charmandari, Amalia Sertedaki, Tomoshige Kino, Christina Merakou, Dax A. Hoffman, Michael M. Hatch, Darrell E. Hurt, Lin Lin, Paraskevi Xekouki, Constantine A. Stratakis, and George P. Chrousos. A novel point mutation in the kcnj5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension. The Journal of Clinical Endocrinology & Metabolism, 97(8):E1532–E1539, August 2012. URL: http://dx.doi.org/10.1210/jc.2012-1334, doi:10.1210/jc.2012-1334. This article has 108 citations.](https://doi.org/10.1210/jc.2012-1334) [2. (Hupfeld2021miR208b) Julia Hupfeld, Maximilian Ernst, Maria Knyrim, Stephanie Binas, Udo Kloeckner, Sindy Rabe, Katja Quarch, Danny Misiak, Matthew Fuszard, Claudia Grossmann, Michael Gekle, and Barbara Schreier. Mir-208b reduces the expression of kcnj5 in a cardiomyocyte cell line. Biomedicines, 9(7):719, June 2021. URL: http://dx.doi.org/10.3390/biomedicines9070719, doi:10.3390/biomedicines9070719. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biomedicines9070719) [3. (Hattangady2016Mutated) Namita G Hattangady, Shigehiro Karashima, Lucy Yuan, Daniela Ponce-Balbuena, José Jalife, Celso E Gomez-Sanchez, Richard J Auchus, William E Rainey, and Tobias Else. Mutated kcnj5 activates the acute and chronic regulatory steps in aldosterone production. Journal of Molecular Endocrinology, 57(1):1–11, July 2016. URL: http://dx.doi.org/10.1530/jme-15-0324, doi:10.1530/jme-15-0324. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/jme-15-0324) [4. (Mulatero2012Role) Paolo Mulatero, Silvia Monticone, William E. Rainey, Franco Veglio, and Tracy Ann Williams. Role of kcnj5 in familial and sporadic primary aldosteronism. Nature Reviews Endocrinology, 9(2):104–112, December 2012. URL: http://dx.doi.org/10.1038/nrendo.2012.230, doi:10.1038/nrendo.2012.230. This article has 95 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrendo.2012.230) [5. (Scholl2013New) Ute I. Scholl and Richard P. Lifton. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the k+ channel kcnj5. Current Opinion in Nephrology and Hypertension, 22(2):141–147, March 2013. URL: http://dx.doi.org/10.1097/mnh.0b013e32835cecf8, doi:10.1097/mnh.0b013e32835cecf8. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/mnh.0b013e32835cecf8) [6. (Meyer2023Relevance) Karisa M. Meyer, Nipun Malhotra, Jung seo Kwak, and Mona El Refaey. Relevance of kcnj5 in pathologies of heart disease. International Journal of Molecular Sciences, 24(13):10849, June 2023. URL: http://dx.doi.org/10.3390/ijms241310849, doi:10.3390/ijms241310849. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241310849) [7. (Hibino2010Inwardly) Hiroshi Hibino, Atsushi Inanobe, Kazuharu Furutani, Shingo Murakami, Ian Findlay, and Yoshihisa Kurachi. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiological Reviews, 90(1):291–366, January 2010. URL: http://dx.doi.org/10.1152/physrev.00021.2009, doi:10.1152/physrev.00021.2009. This article has 1713 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00021.2009) [8. (Shalomov2022A) Boris Shalomov, Reem Handklo‐Jamal, Haritha P. Reddy, Neta Theodor, Amal K. Bera, and Nathan Dascal. A revised mechanism of action of hyperaldosteronism‐linked mutations in cytosolic domains of girk4 (kcnj5). The Journal of Physiology, 600(6):1419–1437, January 2022. URL: http://dx.doi.org/10.1113/JP282690, doi:10.1113/jp282690. This article has 5 citations.](https://doi.org/10.1113/JP282690) [9. (Tauber2014Pharmacology) P. Tauber, D. Penton, J. Stindl, E. Humberg, I. Tegtmeier, C. Sterner, F. Beuschlein, M. Reincke, J. Barhanin, S. Bandulik, and R. Warth. Pharmacology and pathophysiology of mutated kcnj5 found in adrenal aldosterone-producing adenomas. Endocrinology, 155(4):1353–1362, April 2014. URL: http://dx.doi.org/10.1210/en.2013-1944, doi:10.1210/en.2013-1944. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2013-1944) [10. (Maurya2023Outlining) Svetlana Maurya, Robert W. Mills, Konstantin Kahnert, David Y. Chiang, Giorgia Bertoli, Pia R. Lundegaard, Marta Perez-Hernandez Duran, Mingliang Zhang, Eli Rothenberg, Alfred L. George, Calum A. MacRae, Mario Delmar, and Alicia Lundby. Outlining cardiac ion channel protein interactors and their signature in the human electrocardiogram. Nature Cardiovascular Research, 2(7):673–692, July 2023. URL: http://dx.doi.org/10.1038/s44161-023-00294-y, doi:10.1038/s44161-023-00294-y. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s44161-023-00294-y) [11. (Nishikido2020Regulation) Ayaka Nishikido, Takashi Okamura, Yasuyo Nakajima, Emi Ishida, Tomoko Miyamoto, Akiko-Katano Toki, Shunichi Matsumoto, Satoshi Yoshino, Kazuhiko Horiguchi, Tsugumichi Saito, Eijiro Yamada, Atsushi Ozawa, Yuki Shimoda, Tetsunari Oyama, and Masanobu Yamada. Regulation of the kcnj5 gene by sf-1 in the adrenal cortex: complete genomic organization and promoter function. Molecular and Cellular Endocrinology, 501:110657, February 2020. URL: http://dx.doi.org/10.1016/j.mce.2019.110657, doi:10.1016/j.mce.2019.110657. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2019.110657) [12. (Binas2019miR221) Stephanie Binas, Maria Knyrim, Julia Hupfeld, Udo Kloeckner, Sindy Rabe, Sigrid Mildenberger, Katja Quarch, Nicole Strätz, Danny Misiak, Michael Gekle, Claudia Grossmann, and Barbara Schreier. Mir-221 and -222 target cacna1c and kcnj5 leading to altered cardiac ion channel expression and current density. Cellular and Molecular Life Sciences, 77(5):903–918, July 2019. URL: http://dx.doi.org/10.1007/s00018-019-03217-y, doi:10.1007/s00018-019-03217-y. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03217-y)